Nurix Therapeutics, Inc. NRIX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s retained earnings?
- Nurix Therapeutics, Inc. (NRIX) reported retained earnings of -$1.09B in Q4 2025.
- How has Nurix Therapeutics, Inc.'s retained earnings changed year-over-year?
- Nurix Therapeutics, Inc.'s retained earnings decreased by 37.1% year-over-year, from -$795.12M to -$1.09B.
- What is the long-term trend for Nurix Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s retained earnings has grown at a 57.4% compound annual growth rate (CAGR), from -$103.7M to -$1B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.